Skip to content

investigation of the effect of propranolol on sympathetic skin response and bone mass density of burn patients

investigation of the effect of propranolol on sympathetic skin response and bone mass density of burn patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016111930974N1
Enrollment
200
Registered
2017-01-18
Start date
2016-11-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Burn. Burns and corrosions

Interventions

Intervention 1: The control group will receive placebo for 12 weeks. Intervention 2: The intervention group will recieve 80 mg propranolol / day for 12 weeks and then gradually tapered to discontinue
Placebo
Treatment - Drugs
The control group will receive placebo for 12 weeks
The intervention group will recieve 80 mg propranolol / day for 12 weeks and then gradually tapered to discontinue in 1 week

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: We will include 18 to 50 years old patients experiencing electrical injury 15 days to 3 months prior to the study. Exclusion criteria are as follows: positive history of joint or bone disease; neuropathy (central or peripheral); diabetes mellitus or consumption of any drug affecting the autonomic nervous system; any cast; skin lesion, skin graft, or scar at the sites of SSR recording or stimulus (palms, soles, wrists, or ankles) that make technical problems for SSR recording; contraindications of propranolol administration such as bronchial asthma, pronounced bradycardia, manifest heart failure, second and third degree heart block, hypersensitivity to propranolol. Any patient with evidence of peripheral neuropathy on 4 limb electrophysiologic study (done at the beginning of the study after filling in the written informed consent).

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Bone mass desitometery. Timepoint: Before study and 3 months, 9 months after study. Method of measurement: Bone mass densitometery.;Sympathetic skin response. Timepoint: Before study and 3 months, 9 months after study. Method of measurement: SSR.

Secondary

MeasureTime frame
Decreased blood pressure. Timepoint: Before and every 2 weeks after study. Method of measurement: Mesurment of blood pressure.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZohreh Eshghi

Shiraz University of Medical Sciences

eshghi_z@sums.ac.ir+98 71 3231 9040

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026